These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32671100)

  • 1. Serum GDF15, a Promising Biomarker in Obese Patients Undergoing Heart Surgery.
    Sarkar S; Legere S; Haidl I; Marshall J; MacLeod JB; Aguiar C; Lutchmedial S; Hassan A; Brunt KR; Kienesberger P; Pulinilkunnil T; Légaré JF
    Front Cardiovasc Med; 2020; 7():103. PubMed ID: 32671100
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
    Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
    Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Teramoto K; Nochioka K; Sakata Y; Kato ET; Nishimura K; Shimokawa H; Yasuda S;
    Int J Cardiol; 2024 Jul; 407():132093. PubMed ID: 38663803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Differentiation Factor-15 as a Biomarker of Obese Pre-diabetes and Type 2 Diabetes Mellitus in Indian Subjects: A Case-control Study.
    Roy D; Purohit P; Modi A; Khokhar M; Shukla RKG; Chaudhary R; Sankanagoudar S; Sharma P
    Curr Diabetes Rev; 2022; 18(1):e010321189862. PubMed ID: 33397240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial fluid levels of growth differentiation factor 15 in patients with or without coronary artery disease: a prospective study.
    Yuan Z; Li H; Sun Y; Qiu J; Xu H; Liu J; Zhou M; Chen A; Ye X; Wang Z; Zhao Q
    Ann Transl Med; 2020 Feb; 8(4):113. PubMed ID: 32175406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.
    Schernthaner-Reiter MH; Kasses D; Tugendsam C; Riedl M; Peric S; Prager G; Krebs M; Promintzer-Schifferl M; Clodi M; Luger A; Vila G
    Eur J Endocrinol; 2016 Dec; 175(6):623-631. PubMed ID: 27926473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 is decreased by kidney transplantation.
    Connelly PW; Yan AT; Nash MM; Lok CE; Gunaratnam L; Prasad GVR
    Clin Biochem; 2019 Nov; 73():57-61. PubMed ID: 31361994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes.
    He X; Su J; Ma X; Lu W; Zhu W; Wang Y; Bao Y; Zhou J
    Cardiovasc Diabetol; 2020 Mar; 19(1):40. PubMed ID: 32222153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone increases CCL-2 expression in visceral adipose tissue from obese women of reproductive age.
    Crisosto N; Flores C; Maliqueo M; Echiburú B; Vásquez J; Maluenda F; Sir-Petermann T
    Mol Cell Endocrinol; 2017 Mar; 444():59-66. PubMed ID: 28161330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay.
    Kempf T; Horn-Wichmann R; Brabant G; Peter T; Allhoff T; Klein G; Drexler H; Johnston N; Wallentin L; Wollert KC
    Clin Chem; 2007 Feb; 53(2):284-91. PubMed ID: 17185363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkers.
    Hao X; Zhang Z; Kong J; Ma R; Mao C; Peng X; Ru K; Liu L; Zhao C; Mo X; Cai M; Yu X; Lin Q
    Cardiooncology; 2024 Sep; 10(1):56. PubMed ID: 39232830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
    Lewis LK; Raudsepp SD; Prickett TCR; Yandle TG; Doughty RN; Frampton CM; Pemberton CJ; Richards AM
    Clin Chem; 2019 Sep; 65(9):1115-1124. PubMed ID: 31092393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
    Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
    Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
    Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
    Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.